The Checkup by Singlecare

DECEMBER 26, 2024

2024 has been a busy year for new drugs. Notable new drugs approved in 2024 By staying up-to-date on the latest drug approvals, pharmacists can give new advice when working with patients and other healthcare providers. Zelsuvmi (berdazimer) Zelsuvmi received the green light from the FDA on January 5, 2024.

FDA

The Checkup by Singlecare

DECEMBER 31, 2024

For instance, according to a 2024 report from the American Dental Association Science and Research Institute , the use of corticosteroids for surgical tooth extractions only offers a trivial reduction in pain, and evidence is low for their efficacy in treating this condition. As Claudia Cometa, Pharm.D.,

Dosage

PharmTech

JUNE 19, 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish Felicity Thomas June 25th 2024 Podcast In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish. Poor API Quality Threatens a Healthy Supply. Pharmaceutical Technology 2025 49 (4). link] Thomas, F. PharmTech.com.

Dosage

PharmTech

JUNE 23, 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish Felicity Thomas June 25th 2024 Podcast In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Dosage

European Pharmaceutical Review

NOVEMBER 1, 2024

percent between 2024 and 2033. Packaging types generating demand in the market include tamper-proofing drug packaging against counterfeiting, as well as single-dosage packaging, according to the research. The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12

Packaging

The Checkup by Singlecare

MARCH 11, 2025

In a 2024 KFF survey, one out of every eight Americans said they had taken a GLP-1 drug like semaglutide. Aside from how you take Rybelsus or Ozempic , the dosage forms and dosing schedule are the main differences. The standard dosage for Rybelsus is 714 mg, once daily, while an injection like Ozempic only requires a 0.52

Compounding

Pharmacy Times

JULY 22, 2025

FluMist (live intranasal influenza vaccine; AstraZeneca) was approved in September 2024 for self- and caregiver administration for individuals aged 2 to 49 years. 8 This percentage is lower than the previous season (53%), which contributed to 250 pediatric deaths during the 2024-2025 influenza season. September 17, 2024.

Vaccines

Pharma Manufacturing

JUNE 17, 2025

According to the results of CRB’s Horizons: Life Sciences survey released in October 2024, 75% of respondents are using or plan to use continuous technologies almost exclusively within the next five years, based on a survey of 500 industry leaders including therapeutic developers and CDMO executives.

Dosage

The Checkup by Singlecare

APRIL 15, 2025

But in December 2024, the FDA announced that the tirzepatide shortage had ended. Dosage Mounjaro is FDA approved as a weekly injection from a prefilled autoinjector pen. Dosages are standardized, with a starting dose of 2.5 So, why is compounded tirzepatide even available? The answer has to do with supply and demand.

Compounding

Pharma Marketing Network

JULY 18, 2025

A 2024 report by McKinsey found that personalized, AI-driven healthcare campaigns had 3x higher engagement rates than traditional strategies. AI doesn’t just automate—it learns. Natural language processing (NLP) tools analyze user intent and sentiment, helping refine messages that resonate emotionally.

HIPAA

Pharmacy Times

AUGUST 7, 2025

Suggestions for providers featured in the guidelines include determining if opioids should take place, selecting appropriate dosages, determining prescription length and follow-up, and assessing and reducing risks of misuse, overdose, and opioid use disorder. Published May 6, 2024. MMWR Recommendations and Reports. 2022;71(3):1-95.

Labelling

Pharmacy Times

JUNE 27, 2025

5 Phase 3 ECHO Trial: A New Frontline Option The approval was supported by data from the phase 3 ECHO trial (NCT02972840), presented at the 2024 European Hematology Association Hybrid Congress. June 21, 2024. Deaths were reported in 5 TN and 6 R/R patients. The trial enrolled 598 patients 65 years or older with TN MCL. Hemasphere.

FDA

PharmTech

JUNE 6, 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish Felicity Thomas June 25th 2024 Podcast In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish. Guidance on Quality Culture Standards Matt Cushing ; Susan J. Guidance on Quality Culture Standards Matt Cushing ; Susan J.

Dosage

The Checkup by Singlecare

MARCH 18, 2025

Injection Ozempic and Wegovy: Injection Rybelsus: Oral tablet What is the standard dosage? Side effects will vary by drug and dosage. You may need a dosage adjustment and close monitoring. Mounjaro Zepbound Ozempic Rybelsus Wegovy What form(s) does the drug come in? Starting dose: 2.5 mg injected once a week. of body weight).

Labelling

Pharmacy Times

JUNE 20, 2025

Selection of an appropriate OTC analgesic should take into consideration various patient factors, including the patient’s overall health status, current medical conditions, and medication profile, as well as patient preferences, which are often influenced by dosage form, required dosing intervals, and cost of OTC medication. 2014.01.108 6.

Compounding Pharmacies

Pharmacy Times

JUNE 25, 2025

This phase 1b clinical trial, conducted between September 2023 and November 2024, was designed to build on promising preclinical data that demonstrated improved efficacy and tolerability with continuous SC lenalidomide delivery in murine MM models. It will be interesting to see what dosage form these data prompt the future development of.

Immunization

The Checkup by Singlecare

MARCH 4, 2025

Oral capsules Oral capsules Oral tablets What is the standard dosage? While both drugs are effective, a study published in December 2024 found that, on average, people who used Zepbound lost an average of 20.2% The frequency varies by dosage, with higher doses generally causing a higher frequency of side effects.

Insurance Coverage

PharmTech

JULY 4, 2025

One example is a canalicular gel device (Lacrifill, Nordic Pharma) introduced in June 2024 (7). 2024 11 (2), 179. Times 2024 49 (11). 2024 8 (5). Recent developments have helped address many of these issues. Seeing the Future: A Review of Ocular Therapy. DOI: 10.3390/bioengineering11020179 Chandel, A. and Kandav, G.

Dosage

PharmaVoice

JUNE 27, 2025

FDA approvals dropped in May to 14 drugs after hitting 20 and above in the two months prior, but the total of 84 OKs so far in 2025 is the second only to 2024’s record high for the first part of the year, according to Clarivate. The FDA approved the updated formulation, which will be sold under the brand name Yeztugo, earlier this month.

FDA

The Checkup by Singlecare

JUNE 25, 2025

Centers for Disease Control and Prevention (CDC) , 2024) Type 2 diabetes in the U.S. CDC , 2024) The percentage of people with severe obesity, defined as a BMI of 40 or higher, is slowly growing: It was 9.7% CDC, 2024) How many people use Mounjaro for Type 2 diabetes? is highest among people ages 65 and older.

Insurance

Pharmacy Times

JUNE 17, 2025

A group of experts will present an encore abstract titled " Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using Real-World Data " at the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20.

Dosage

Pharmacy Times

JUNE 17, 2025

CE hours from BCOP Updates 2024 and the Annual Conference 2025, featuring topics such as acute leukemia, cellular therapy for solid tumors, and the pharmacist’s role in serious illness conversations. HOPA has selected 4.0 Additional information is available here. Subscribe Now!

Mail-Order Pharmacies

Pharmacy Times

JUNE 27, 2025

Generics are exact chemical copies of small-molecule drugs, with identical active ingredients, strengths, dosage forms, and routes of administration. Updated June 20, 2024. 2024 US Generic & Biosimilar Medicines Savings Report. September 2024. REFERENCES 1. Accessed May 13, 2025. Biosimilar medicines: overview.

Compounding Pharmacies

Pharmacy Times

JULY 10, 2025

2 Guiding prescribers and patients through initiation of lumatperone, adjusting dosage amounts, and switching from other antipsychotics, emphasizing its favorable relapse reduction profile is key in preventing relapse.

FDA

Pharmacy Times

JULY 4, 2025

This single-center, retrospective, observational study included data from electronic health records and specialty pharmacies from January 1, 2023, to June 1, 2024, with specialty pharmacy dispensing data specifically used to identify patients who had received Humira and a biosimilar during the study period.

Specialty Pharmacies

PharmTech

JUNE 23, 2025

Pharmacist weighing chemical | Image Credit: © Kzenon - stock.adobe.com Performing calculations for the formulation of pharmaceutical dosage forms and related preparations is a key activity in compounding. Active moiety calculations determine the drug amount needed to prepare the dosage form quantity. Policy-exception salts.

Compounding

Hospital Pharmacy Europe

APRIL 14, 2025

The National Child Mortality Database report on child deaths related to asthma and allergies was released in December 2024, providing sobering insights. Pharmacist Ravijyot Saggu offers an expert summary, emphasising key points from the thematic report and discussing necessary future actions. Child deaths due to Asthma or Anaphylaxis.

Health and Personal Care Stores

Pharmacy Times

AUGUST 7, 2025

Side effects can interfere with daily life, reduce quality of life, and even cause patients to reduce the dosage or discontinue the drug completely.¹ Published online September 10, 2024. Up to 87% of individuals who take opioids for a long period time say they have OIC. Journal of Clinical Oncology. doi:10.1200/jco.24.00381

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 22, 2025

By incorporating a patient's genetic profile into therapeutic decision-making, pharmacists can identify optimal drug choices and dosages while minimizing the risk of adverse events (AEs). Developed in partnership with InterSystems, the platform uses proprietary algorithms to personalize drug selection and dosage.

Compounding Pharmacies

PharmTech

JULY 28, 2025

Current Opinion in Toxicology, 2024 , 40, 100504, Burden, N. June 25th 2024 Drug Solutions Podcast: Growth and Advancements in Fill/Finish Felicity Thomas In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish. British Toxicology Society. New Approach Methodologies (NAMs). thebts.org.

Dosage

Pharmacy Times

JUNE 19, 2025

The field is expanding into autoimmune diseases, with nononcology trials representing 51% of the pipeline by late 2024. Development Trends: Oncology at the Forefront Gene therapy currently ranks third among therapeutic focus areas, with 2151 compounds in development in 2024 ( Figure ).

Compounding

Pharmacy Times

JUNE 20, 2025

August 8, 2024. Updated January 19, 2024. LinkedIn Workplace Learning Report 2024. American Oncology Network. Accessed May 15, 2025. How your oncology peers manage the complexities of care. Oncology Live ®. December 13, 2018. Accessed May 15, 2025. Desimone R. Improve work performance with a focus on employee development.

Compounding

Drug Topics

AUGUST 2, 2025

The drug was studied as a 300 mg monotherapy dosage. Updated October 1, 2024. August 28, 2024. Other updates included revising primary hyperlipidemia to hypercholesterolemia to accurately focus on LDL-C reduction. ClinicalTrials.gov identification: NCT05763875. Accessed August 1, 2025. Biscaldi L. Drug Topics.

Labelling

Pharmacy Times

JUNE 27, 2025

January 17, 2024. 2024;25(1):336. doi:10.1186/s13063-024-08174-x 7. Psychedelic Pharmacists Association is working to promote, establish the role of the pharmacist in psychedelic-assisted therapy. Pharmacy Times. Accessed May 16, 2025. About the PPA. Psychedelic Pharmacists Association. Accessed May 16, 2025.

Compounding Pharmacies

Pharmaceutical Commerce

JUNE 9, 2025

Over the past couple years, the demand for this RSV vaccine has continued to be high; in fact, Sanofi had announced in October 2023 that the extraordinary demand had caused shortages impacting the 2023-2024 season. As of now, supply for this coming season matches last year’s total dosage, with production expected to continue.

Vaccines

PharmTech

JULY 24, 2025

June 25th 2024 Drug Solutions Podcast: Growth and Advancements in Fill/Finish Felicity Thomas In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish. July 23rd 2025 Overcoming PK/PD Modeling Challenges Cynthia A. July 23rd 2025 Overcoming PK/PD Modeling Challenges Cynthia A.

Dosage

Pharmaceutical Technology

JUNE 27, 2025

Last month, European Commission approved the new subcutaneous (SC) formulation of Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) with a dosage strength of 600 mg/vial, expanding treatment options for various adult solid tumours. Sign up for our daily news round-up! Give your business an edge with our leading industry insights.

Labelling